Author

Peter Richmond

Associate Professor, Division of Paediatrics, University of Western Australia - Cited by 12,537 - Immunization - Infectious diseases - vaccines - otitis media

Biography

Professor Peter Richmond is Head of the Vaccine Trials Group which sits in the Wesfarmers Centre of Vaccines and Infectious Diseases. Professor Richmond is also a Consultant Paediatric Immunologist and Paediatrician at Perth Children’s Hospital (PCH), Head of the Department of Research, PCH and Director of the Child Health Research Network, Child and Adolescent Health Service. He also is the Head of Division of Paediatrics, School of Medicine at the University of Western Australia.
Title
Cited by
Year
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
NI Mazur, J Terstappen, R Baral, A Bardají, P Beutels, UJ Buchholz, ...The Lancet Infectious Diseases 23 (1), e2-e21, 2023202
66
2023
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
L Bravo, I Smolenov, HH Han, P Li, R Hosain, F Rockhold, SAC Clemens, ...The Lancet 399 (10323), 461-472, 2022202
56
2022
Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants
B Kampmann, SA Madhi, I Munjal, EAF Simões, BA Pahud, C Llapur, ...New England Journal of Medicine 388 (16), 1451-1464, 2023202
28
2023
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 …
I Smolenov, HH Han, P Li, C Baccarini, C Verhoeven, F Rockhold, ...The Lancet Infectious Diseases 22 (7), 990-1001, 2022202
12
2022
Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis
MTG Pratt, T Abdalla, PC Richmond, HC Moore, TL Snelling, CC Blyth, ...The Lancet Child & Adolescent Health, 2022202
11
2022
A brief history of MECP2 duplication syndrome: 20-years of clinical understanding
D Ta, J Downs, G Baynam, A Wilson, P Richmond, H LeonardOrphanet Journal of Rare Diseases 17 (1), 131, 2022202
11
2022
Clinician-rated quality of video otoscopy recordings and still images for the asynchronous assessment of middle-ear disease
EMA Alenezi, K Jajko, A Reid, A Locatelli-Smith, CSE McMahen, KFM Tao, ...Journal of telemedicine and telecare 29 (6), 435-443, 2023202
10
2023
The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020–March 2021
A Koirala, HF Gidding, K Vette, K Macartney, D Wurzel, H Marshall, ...The Medical Journal of Australia 217 (1), 43, 2022202
8
2022
Prevalence and subtyping of biofilms present in bronchoalveolar lavage from children with protracted bacterial bronchitis or non-cystic fibrosis bronchiectasis: a cross …
RL Marsh, MJ Binks, HC Smith-Vaughan, M Janka, S Clark, P Richmond, ...The Lancet Microbe 3 (3), e215-e223, 2022202
7
2022
The reliability of video otoscopy recordings and still images in the asynchronous diagnosis of middle-ear disease
EMA Alenezi, K Jajko, A Reid, A Locatelli-Smith, KFM Tao, T Bright, ...International Journal of Audiology 61 (11), 91-923, 2022202
7
2022
Medical Comorbidities in MECP2 Duplication Syndrome: Results from the International MECP2 Duplication Database
D Ta, J Downs, G Baynam, A Wilson, P Richmond, H LeonardChildren 9 (), 633, 2022202
5
2022
B part of it school leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with meningococcal B (4CMenB) vaccine on carriage of Neisseria …
B part of it school leaver study: a repeat cross-sectional study to assess the impact of increasing coverage with meningococcal B (CMenB) vaccine on carriage of Neisseria …M McMillan, AP Koehler, A Lawrence, TR Sullivan, J Bednarz, ...The Journal of Infectious Diseases 225 (), 637-69, 2022202
4
2022
Severity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007–2018
M Sheel, N Wood, K Macartney, J Buttery, N Dinsmore, H Marshall, ...The Pediatric infectious disease journal 1 (6), 507-513, 2022202
4
2022
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
D Wilkins, AC Langedijk, RJ Lebbink, C Morehouse, ME Abram, B Ahani, ...The Lancet Infectious Diseases, 2023202
4
2023
Randomized trial of BCG vaccine to protect against Covid-19 in health care workers
LF Pittet, NL Messina, F Orsini, CL Moore, V Abruzzo, S Barry, R Bonnici, ...New England Journal of Medicine 88 (17), 1582-1596, 20220
3
2023
A prospective study investigating the impact of obesity on the immune response to the quadrivalent influenza vaccine in children and adolescents
M Clarke, SM Mathew, LC Giles, AS Pena, IG Barr, PC Richmond, ...Vaccines 10 (5), 699, 2022202
3
2022
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-02 (PNEU-SICKLE) studyCT Quinn, RT Wiedmann, D Jarovsky, E Lopez-Medina, HM Rodriguez, ...Blood Advances 7 (), 414-421, 20220
3
2023
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
P Villanueva, U Wadia, NW Crawford, NL Messina, TR Kollmann, ...Plos one 17 (6), e06804, 0
2
2022